A comparison of the constant piecewise weighted logrank and Fleming-Harrington tests

Electronic Journal of Statistics

Volumn 8, Issue 1, 2014, Pages 841-860

  Garès, Valérie ^a,b   Andrieu, Sandrine ^a,b   Dupuy, Jean François ^c   Savy, Nicolas ^b,d  

^a Faculté de Médecine Centre Hospitalo universitaire   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c UNIVERSITÉ DE RENNES 1   (France)

^d CNRS   (France)

Author keywords

Alzheimer's disease; Constant piecewise weighted logrank test; Fleming Harrington test; Pitman asymptotic relative efficiency; Prevention trial; Survival data analysis

Indexed keywords

EID: 84904042612     PISSN: 19357524     EISSN: None     Source Type: Journal    
DOI: 10.1214/14-EJS911     Document Type: Article

References (21)

1. Andrieu, S., Gillette, S., Amouyal, K., Nourhashemi, F., Reynish, E., Ousset, P. J., Albarede, J. L., Vellas, B. and Grand- jean, H. (2003). Association of Alzheimer's disease onset with ginkgo biloba and other symptomatic cognitive treatments in a population of women aged 75 years and older from the EPIDOS study. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 58(4) 372-377.
2. Brookmeyer, R. (2007). Forecasting the global burden of Alzheimer's disease. Alzheimer's and Dementia 3(3) 186-191.
3. Brookmeyer, R., Gray, S. and C., K. (1998). Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. American Journal of Public Health 88(9) 1337-1342.
4. DeKosky, S. T. (2008). Ginkgo biloba for prevention of dementia: A randomized controlled trial. Journal of the American Medical Association 300(19) 2253-2262.
5. Fleming, T. R. and Harrington, D. P. (1991). Counting processes and survival analysis. Wiley Series in Probability and Mathematical Statistics: Applied Probability and Statistics. John Wiley & Sons Inc, New York. MR1100924 (92i:60091)
6. [] Garès, V., Andrieu, S., Dupuy, J. F. and Savy, N. (2014). A omnibus test for several hazard alternatives in prevention randomized controlled clinical trials. In revision for Statistics in Medicine.
7. Garès, V., Andrieu, S., Dupuy, J. F. and Savy, N. (2014). About the parameter of Fleming-Harrington's test in prevention randomized controlled trials. Submitted to Journal of Royal Statistical Society - Serie C.
8. Garès, V., Andrieu, S., Dupuy, J. F. and Savy, N. (2014). Supplement to "A comparison of the constant piecewise weighted logrank and Fleming- Harrington tests". DOI:10.1214/14-EJS911SUPP.
9. Gill, R. (1980). Censoring and stochastic integrals. Mathematisch Centrum. MR0596815
10. Halperin, M., Rogot, E., Gurian, J. and Ederer, F. (1967). Sample sizes for medical tirials with special reference to long-term therapy. Bio-metrics 21 13-24.
11. Lakatos, E. (1986). Sample sizes determination in clinical trials with timedependant rates of losses and noncompliance. Controlled Clinical Trials 7 189-199. MR931637
12. Lakatos, E. (1988). Sample sizes based on the log-rank statistic in complex clinical trials. Biometrics 44 229-241. MR931637
13. Lakatos, E. and Lan, K. G. (1992). A comparison of sample size methods for the logrank statistic. Statistics in Medicine 11 179-191.
14. Lyketsos, C. G. (2007). Naproxen and celecoxib do not prevent Alzheimer's disease in early results from a randomized controlled trial. Neurology 68(21) 1800-1808.
15. Schork, M. A. and Remington, R. D. (1967). The determination of sample size in treatment-control comparisons for chronic disease studies in which noncompliance on nonaddherence is a problem. Journal of Chronic Diseases 20 233-239.
16. Shumaker, S. A. (2003). Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: The Women's Health Initiative Memory Study: A randomized controlled trial. Journal of the American Medical Association 289(20) 2651-2662.
17. Shumaker, S. A. (2004). Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. Journal of the American Medical Association 291(24) 2947-2958.
18. Van der Vaart, A. W. (1998). Asymptotic statistics. Cambridge Series in Statistical and Probabilistic Mathematics 3. Cambridge University Press, Cambridge. MR1652247 (2000c:62003)
19. Vellas, B., Coley, N., Ousset, P. J., Berrut, G., Dartigues, J. F., Dubois, B., Grandjean, H., Pasquier, F., Piette, F., Robert, P., Touchon, J., Garnier, P., Mathiex-Fortunet, H. and Andrieu, S. f. (2012). Long-term use of standardised ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): A randomised placebocontrolled trial. Lancet Neurology.
20. [] Wimo, A. and Prince, M. (2012).World Alzheimer report 2012 Technical Report.
21. Zucker, D. M. and Lakatos, E. (1990).Weighted log rank type statistics for comparing survival curves when there is a time lag in the effectiveness of treatment. Biometrika 77 853-864. MR1086695 (92c:62053)